* Orthofix Medical Inc OFIX.OQ reported quarterly adjusted
earnings of 11 cents per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -10 cents. The mean expectation of
five analysts for the quarter was for a loss of 33 cents per
share. Wall Street expected results to range from -35 cents
to -32 cents per share.
* Revenue rose 7.7% to $188.61 million from a year ago;
analysts
expected $184.13 million.
* Orthofix Medical Inc's reported EPS for the quarter was a
loss
of 95 cents.
* The company reported a quarterly loss of $36.02 million.
* Orthofix Medical Inc shares had fallen by 4.3% this
quarter and
gained 3.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 233.3% in the last three months.
* In the last 30 days, two analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Orthofix Medical
Inc is $20.00
This summary was machine generated from LSEG data May 8 at 09:18
a.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.33 0.11 Beat
Dec. 31 2023 -0.08 0.02 Beat
Sep. 30 2023 -0.21 0.07 Beat
Jun. 30 2023 -0.47 0.02 Beat